Published in Dtsch Arztebl Int on December 13, 2013
Clinical characteristics and molecular pathology of skull ectopic thyroid cancer. Ann Transl Med (2016) 0.75
Metastatic cerebellar tumor of papillary thyroid carcinoma mimicking cerebellar hemangioblastoma. Springerplus (2016) 0.75
Clinical outcomes of a cohort of patients with central nervous system metastases from thyroid cancer. Endocr Connect (2016) 0.75
Revised American Thyroid Association management guidelines for patients with thyroid nodules and differentiated thyroid cancer. Thyroid (2009) 35.34
Long-term impact of initial surgical and medical therapy on papillary and follicular thyroid cancer. Am J Med (1994) 8.39
Growth patterns in the developing brain detected by using continuum mechanical tensor maps. Nature (2000) 5.48
Papillary and follicular thyroid carcinoma. N Engl J Med (1998) 4.95
Second primary malignancy risk after radioactive iodine treatment for thyroid cancer: a systematic review and meta-analysis. Thyroid (2009) 2.79
Poorly differentiated thyroid carcinoma: the Turin proposal for the use of uniform diagnostic criteria and an algorithmic diagnostic approach. Am J Surg Pathol (2007) 2.75
Management of papillary and follicular (differentiated) thyroid cancer: new paradigms using recombinant human thyrotropin. Endocr Relat Cancer (2002) 1.76
Distant metastases in papillary thyroid carcinoma: 100 cases observed at one institution during 5 decades. J Clin Endocrinol Metab (1995) 1.71
Prognosis and treatment of brain metastases in thyroid carcinoma. J Clin Endocrinol Metab (1997) 1.59
Management of brain metastases from thyroid carcinoma: a study of 16 pathologically confirmed cases over 25 years. Cancer (2003) 1.32
Long-term outcome in 215 children and adolescents with papillary thyroid cancer treated during 1940 through 2008. World J Surg (2010) 1.20
Recurrence of papillary thyroid carcinoma presenting as a focal neurologic deficit. Arch Intern Med (1986) 1.16
Cerebellopontine angle metastasis from papillary carcinoma of the thyroid: case report and literature review. Surg Neurol (2000) 1.00
Cerebellar mass as a primary presentation of papillary thyroid carcinoma: case report and literature review. Head Neck Oncol (2009) 1.00
Cerebellar metastasis as first metastasis from papillary thyroid carcinoma. Endocr J (2005) 0.95
Papillary thyroid carcinoma with brain metastases: an unusual 10-year-survival case. Thyroid (2010) 0.94
Survival of differentiated thyroid carcinoma studied in 500 patients. J Clin Oncol (1997) 0.93
Management of intracranial metastases of differentiated carcinoma of thyroid. J Neurooncol (1994) 0.91
The clinical course of poorly differentiated thyroid carcinoma (insular carcinoma) - own observations. Endokrynol Pol (2010) 0.90
Radioiodine treatment of metastatic thyroid cancer: relative efficacy and side effect profile of preparation by thyroid hormone withdrawal versus recombinant human thyrotropin. Thyroid (2012) 0.90
Brain metastasis from differentiated thyroid cancer in patients treated with radioiodine for bone and lung lesions. Ann Nucl Med (2000) 0.88
Thyroid cancer in children: the Royal Marsden Hospital experience. Eur J Cancer (2000) 0.87
Brain metastases in well-differentiated carcinoma of the thyroid. Tumori (1997) 0.86
Brain metastases in patients with well-differentiated thyroid carcinoma: study of 11 cases. Eur J Surg Oncol (1990) 0.85
Sella turcica metastasis from follicular carcinoma of thyroid. Neurol Res (2004) 0.85
Primary tumour size is a prognostic parameter in patients suffering from differentiated thyroid carcinoma with extrathyroidal growth: results of the MSDS trial. Eur J Endocrinol (2010) 0.84
Brain metastasis from follicular thyroid carcinoma: treatment with sorafenib. Thyroid (2012) 0.84
[Procedure guideline for radioiodine therapy and 131iodine whole-body scintigraphy in paediatric patients with differentiated thyroid cancer]. Nuklearmedizin (2007) 0.83
Primary tumour diameter as a risk factor for advanced disease features of differentiated thyroid carcinoma. Clin Endocrinol (Oxf) (2008) 0.83
Pituitary metastasis of follicular thyroid carcinoma. Horm Res (2004) 0.83
Peace of mind for patients with differentiated thyroid cancer? Nuklearmedizin (2013) 0.82
Histology does not influence prognosis in differentiated thyroid carcinoma when accounting for age, tumour diameter, invasive growth and metastases. Eur J Endocrinol (2009) 0.82
Radioiodine I-31 therapy in the management of thyroid cancer. A prospective study. Cancer (1977) 0.81
Intrathyroideal papillary thyroid carcinoma presenting with a solitary brain metastasis. Endocrine (2004) 0.77
[Results of radioiodine therapy in 47 patients with distant metastases of differentiated thyroid carcinoma]. Nihon Igaku Hoshasen Gakkai Zasshi (1991) 0.77
Metastatic differentiated carcinoma of the thyroid and radioiodine. Australas Radiol (1987) 0.77
Prognostic factors in high-grade osteosarcoma of the extremities or trunk: an analysis of 1,702 patients treated on neoadjuvant cooperative osteosarcoma study group protocols. J Clin Oncol (2002) 10.03
Primary metastatic osteosarcoma: presentation and outcome of patients treated on neoadjuvant Cooperative Osteosarcoma Study Group protocols. J Clin Oncol (2003) 3.93
Osteosarcoma relapse after combined modality therapy: an analysis of unselected patients in the Cooperative Osteosarcoma Study Group (COSS). J Clin Oncol (2005) 3.29
Inflammatory reactions and severe neutropenia in mice lacking the transcriptional repressor Gfi1. Nat Genet (2002) 2.87
Euthyroid goiter with and without nodules--diagnosis and treatment. Dtsch Arztebl Int (2012) 2.79
In childhood acute lymphoblastic leukemia, blasts at different stages of immunophenotypic maturation have stem cell properties. Cancer Cell (2008) 2.78
High-density lipoproteins and their constituent, sphingosine-1-phosphate, directly protect the heart against ischemia/reperfusion injury in vivo via the S1P3 lysophospholipid receptor. Circulation (2006) 2.58
Risk of recurrence and survival after relapse in patients with Ewing sarcoma. Pediatr Blood Cancer (2011) 2.49
Differentiation of malignant and benign cardiac tumors using 18F-FDG PET/CT. J Nucl Med (2012) 2.25
Second and subsequent recurrences of osteosarcoma: presentation, treatment, and outcomes of 249 consecutive cooperative osteosarcoma study group patients. J Clin Oncol (2008) 1.95
Primary disseminated multifocal Ewing sarcoma: results of the Euro-EWING 99 trial. J Clin Oncol (2010) 1.88
The diagnostic imaging of bone metastases. Dtsch Arztebl Int (2014) 1.83
Osteosarcoma of the pelvis: experience of the Cooperative Osteosarcoma Study Group. J Clin Oncol (2003) 1.78
O-(2-[18F]fluoroethyl)-L-tyrosine: uptake mechanisms and clinical applications. Nucl Med Biol (2006) 1.77
Organic cation transporter 2 mediates cisplatin-induced oto- and nephrotoxicity and is a target for protective interventions. Am J Pathol (2010) 1.76
Activation of the ERK and AKT signalling pathway predicts poor prognosis in hepatocellular carcinoma and ERK activation in cancer tissue is associated with hepatitis C virus infection. J Hepatol (2007) 1.71
Local therapy in localized Ewing tumors: results of 1058 patients treated in the CESS 81, CESS 86, and EICESS 92 trials. Int J Radiat Oncol Biol Phys (2003) 1.70
Detection of respiratory tumour motion using intrinsic list mode-driven gating in positron emission tomography. Eur J Nucl Med Mol Imaging (2010) 1.69
Cardiac autonomic dysfunction in Brugada syndrome. Circulation (2002) 1.68
Impact of EWS-ETS fusion type on disease progression in Ewing's sarcoma/peripheral primitive neuroectodermal tumor: prospective results from the cooperative Euro-E.W.I.N.G. 99 trial. J Clin Oncol (2010) 1.65
Extraskeletal osteosarcoma has a favourable prognosis when treated like conventional osteosarcoma. J Cancer Res Clin Oncol (2005) 1.59
Impaired myocardial perfusion and perfusion reserve associated with increased coronary resistance in persistent idiopathic atrial fibrillation. Eur Heart J (2007) 1.58
Scintigraphic imaging of matrix metalloproteinase activity in the arterial wall in vivo. Circulation (2004) 1.57
Leukemic stem cells in childhood high-risk ALL/t(9;22) and t(4;11) are present in primitive lymphoid-restricted CD34+CD19- cells. Cancer Res (2005) 1.55
Impact of sympathetic innervation on recurrent life-threatening arrhythmias in the follow-up of patients with idiopathic ventricular fibrillation. Eur J Nucl Med Mol Imaging (2006) 1.55
Prognostic significance of (18)F-FDG and (99m)Tc-methylene diphosphonate uptake in primary osteosarcoma. J Nucl Med (2002) 1.53
Nutritional status of children and young adults with Ewing sarcoma or osteosarcoma at diagnosis and during multimodality therapy. Pediatr Blood Cancer (2011) 1.44
Creutzfeldt-Jacob disease misdiagnosed as dementia with Lewy bodies. J Neurol (2005) 1.42
Respiratory gating in positron emission tomography: a quantitative comparison of different gating schemes. Med Phys (2007) 1.42
Target antigen expression on a professional antigen-presenting cell induces superior proliferative antitumor T-cell responses via chimeric T-cell receptors. J Immunother (2005) 1.41
Denosumab: a potential new and innovative treatment option for aneurysmal bone cysts. Eur Spine J (2013) 1.41
Non-linkage of familial rhabdoid tumors to SMARCB1 implies a second locus for the rhabdoid tumor predisposition syndrome. Pediatr Blood Cancer (2006) 1.40
Recurrent high-grade leiomyosarcoma with heterologous osteosarcomatous differentiation. Virchows Arch (2005) 1.40
Noninvasive grading of untreated gliomas: a comparative study of MR imaging and 3-(iodine 123)-L-alpha-methyltyrosine SPECT. Radiology (2002) 1.39
Is PET/CT necessary in paediatric oncology? For. Eur J Nucl Med Mol Imaging (2006) 1.39
Direct epicardial mapping predicts the recovery of left ventricular dysfunction in chronic ischaemic myocardium. Eur Heart J (2004) 1.39
Prognostic relevance of activated Akt kinase in node-negative breast cancer: a clinicopathological study of 99 cases. Mod Pathol (2004) 1.26
Osteosarcoma of the spine: experience of the Cooperative Osteosarcoma Study Group. Cancer (2002) 1.25
Craniofacial osteosarcoma Experience of the cooperative German-Austrian-Swiss osteosarcoma study group. Oral Oncol (2007) 1.24
German Association of Endocrine Surgeons practice guideline for the surgical management of malignant thyroid tumors. Langenbecks Arch Surg (2013) 1.23
High expression of focal adhesion kinase (p125FAK) in node-negative breast cancer is related to overexpression of HER-2/neu and activated Akt kinase but does not predict outcome. Breast Cancer Res (2005) 1.19
List mode-driven cardiac and respiratory gating in PET. J Nucl Med (2009) 1.19
Idiopathic left ventricular aneurysm and sudden cardiac death in young adults. Europace (2006) 1.15
Immature CD34+CD19- progenitor/stem cells in TEL/AML1-positive acute lymphoblastic leukemia are genetically and functionally normal. Blood (2002) 1.12
Multiple endocrine neoplasia type 2. Best Pract Res Clin Endocrinol Metab (2010) 1.11
EANM-ESR white paper on multimodality imaging. Eur J Nucl Med Mol Imaging (2008) 1.11
Performance evaluation of the 32-module quadHIDAC small-animal PET scanner. J Nucl Med (2005) 1.11
Impaired relaxation in transgenic mice overexpressing junctin. Cardiovasc Res (2003) 1.10
Ewing sarcoma: clinical state-of-the-art. Pediatr Hematol Oncol (2012) 1.09
Glucose transporter 1 expression, tumor proliferation, and iodine/glucose uptake in thyroid cancer with emphasis on poorly differentiated thyroid carcinoma. Clin Nucl Med (2012) 1.08
Synthetic lethality screens reveal RPS6 and MST1R as modifiers of insulin-like growth factor-1 receptor inhibitor activity in childhood sarcomas. Cancer Res (2010) 1.08
Biallelic inactivation of the SDHC gene in renal carcinoma associated with paraganglioma syndrome type 3. Endocr Relat Cancer (2012) 1.05
Is whole-body FDG-PET valuable for health screening? Against. Eur J Nucl Med Mol Imaging (2005) 1.05
Ovarian function following pelvic irradiation in prepubertal and pubertal girls and young adult women. Strahlenther Onkol (2005) 1.05
Diagnostic value of [(18)F]-FDG PET/CT in children with fever of unknown origin or unexplained signs of inflammation. Eur J Nucl Med Mol Imaging (2010) 1.05
Significant benefit of multimodal imaging: PET/CT compared with PET alone in staging and follow-up of patients with Ewing tumors. J Nucl Med (2007) 1.04
Human gammadelta T cells as mediators of chimaeric-receptor redirected anti-tumour immunity. Br J Haematol (2004) 1.04
Whole lung irradiation in patients with exclusively pulmonary metastases of Ewing tumors. Toxicity analysis and treatment results of the EICESS-92 trial. Strahlenther Onkol (2008) 1.04
Diffuse sclerosing variant of papillary thyroid carcinoma: lack of BRAF mutation but occurrence of RET/PTC rearrangements. Mod Pathol (2007) 1.03
Autonomic modulation and antiarrhythmic therapy in a model of long QT syndrome type 3. Cardiovasc Res (2010) 1.03
5-pyrrolidinylsulfonyl isatins as a potential tool for the molecular imaging of caspases in apoptosis. J Med Chem (2006) 1.01
Unexpected finding of elevated glucose uptake in fibrous dysplasia mimicking malignancy: contradicting metabolism and morphology in combined PET/CT. Eur Radiol (2006) 1.01
Acute renal failure due to primary bilateral renal large B-cell lymphoma: diagnostics and follow-up by FDG-PET/CT. Clin Nucl Med (2009) 1.00
Heart-directed expression of a human cardiac isoform of cAMP-response element modulator in transgenic mice. J Biol Chem (2004) 1.00
Skip metastases in osteosarcoma: experience of the Cooperative Osteosarcoma Study Group. J Clin Oncol (2006) 0.98
Transgenic triadin 1 overexpression alters SR Ca2+ handling and leads to a blunted contractile response to beta-adrenergic agonists. Cardiovasc Res (2004) 0.97
Non-invasive imaging of acute renal allograft rejection in rats using small animal F-FDG-PET. PLoS One (2009) 0.97
[Should all patients with thyroid nodules > or = 1 cm undergo fine-needle aspiration biopsy?]. Nuklearmedizin (2009) 0.97
High-density lipoprotein stimulates myocardial perfusion in vivo. Circulation (2004) 0.96
Significant differences in central imaging of histamine-induced itch between atopic dermatitis and healthy subjects. Eur J Pain (2008) 0.96
Radiotherapy in Ewing tumors of the vertebrae: treatment results and local relapse analysis of the CESS 81/86 and EICESS 92 trials. Int J Radiat Oncol Biol Phys (2005) 0.96
CD4+CD25+ T-cell populations expressing CD134 and GITR are associated with disease activity in patients with Wegener's granulomatosis. Nephrol Dial Transplant (2008) 0.96
Differential expression of microRNA 181b and microRNA 21 in hyperplastic polyps and sessile serrated adenomas of the colon. Virchows Arch (2009) 0.96
Dynamic 18F-fluoride small animal PET to noninvasively assess renal function in rats. Eur J Nucl Med Mol Imaging (2008) 0.96
Radioligand Therapy With 177Lu-PSMA-617 as A Novel Therapeutic Option in Patients With Metastatic Castration Resistant Prostate Cancer. Clin Nucl Med (2016) 0.96
Regulatory BCL2 promoter polymorphism (-938C>A) is associated with adverse outcome in patients with prostate carcinoma. Int J Cancer (2011) 0.95
Cerebral AL lambda-amyloidoma: clinical and pathomorphological characteristics. Review of the literature and of a patient. Amyloid (2007) 0.95
Impaired cardiac contraction and relaxation and decreased expression of sarcoplasmic Ca2+-ATPase in mice lacking the CREM gene. FASEB J (2002) 0.94
Potential of noninvasive serial assessment of acute renal allograft rejection by 18F-FDG PET to monitor treatment efficiency. J Nucl Med (2010) 0.94
Abnormal myocardial presynaptic norepinephrine recycling in patients with Brugada syndrome. Circulation (2004) 0.93
Detection and differentiation of inflammatory versus fibromatous Crohn's disease strictures: prospective comparison of 18F-FDG-PET/CT, MR-enteroclysis, and transabdominal ultrasound versus endoscopic/histologic evaluation. Inflamm Bowel Dis (2012) 0.93
Ewing's sarcoma and peripheral primitive neuroectodermal tumor cells produce large quantities of bioactive tumor necrosis factor-alpha (TNF-alpha) after radiation exposure. Int J Radiat Oncol Biol Phys (2003) 0.93
Radiofluorinated pyrimidine-2,4,6-triones as molecular probes for noninvasive MMP-targeted imaging. ChemMedChem (2010) 0.92
Rare expression of target antigens for immunotherapy on disseminated tumor cells in breast cancer patients without overt metastases. Int J Mol Med (2003) 0.92
Evaluation and comparison of 11C-choline uptake and calcification in aortic and common carotid arterial walls with combined PET/CT. Eur J Nucl Med Mol Imaging (2009) 0.92
[18F]Fluorodeoxyglucose positron emission tomography for detection of bone marrow involvement in children and adolescents with Hodgkin's lymphoma. J Clin Oncol (2011) 0.92
c-KIT-expressing Ewing tumour cells are insensitive to imatinib mesylate (STI571). Cancer Chemother Pharmacol (2002) 0.91
FFPE tissue as a feasible source for gene expression analysis--a comparison of three reference genes and one tumor marker. Pathol Res Pract (2013) 0.91